Oncology

Hidden First Signs of Leukemia That Doctors Often Miss in Primary Care

by Nancy Ogbonna - 0391

Hidden First Signs of Leukemia That Doctors Often Miss in Primary Care Please like and subscribe if you enjoyed this video :-)   Introduction Leukemia accounts for approximately 3.2% of all new cancer cases in the U.S., yet its early signs

Why MDS Can Be Misdiagnosed: Hidden Links to Pernicious Anemia

by Nancy Ogbonna - 0391

Why MDS Can Be Misdiagnosed: Hidden Links to Pernicious Anemia Please like and subscribe if you enjoyed this video :-)   Introduction Vitamin B12 deficiency is a growing concern, especially among older adults. In the U.S. and UK, it affects roughly

Use of AI in Predicting Cancer Recurrence and Patient Outcomes

by Nancy Ogbonna - 0194

Use of AI in Predicting Cancer Recurrence and Patient Outcomes Please like and subscribe if you enjoyed this video :-)   Abstract This paper explores the application of artificial intelligence (AI) in predicting cancer recurrence and patient outcomes. It examines recent advancements in

How AI Achieves 94% Accuracy in Early Disease Detection: New Research Findings

by Nancy Ogbonna - 0598

How AI Achieves 94% Accuracy in Early Disease Detection: New Research Findings Please like and subscribe if you enjoyed this video :-)   Introduction Diagnostic errors impact more than 12 million Americans annually, with associated costs exceeding $100 billion. However, artificial

Genetic Testing for Cancer: New Evidence Questions Universal Screening Protocol

by Nancy Ogbonna - 0253

Genetic Testing for Cancer: New Evidence Questions Universal Screening Protocol Quick video summary of the detailed article below. Introduction Every year, over a million people receive a cancer diagnosis, yet only 6.8% of patients undergo genetic testing within two years. This is

Targeted Therapy vs. Immunotherapy in Oncology: Advancements and Comparisons Since 2022

by Nancy Ogbonna - 0385

Targeted Therapy vs. Immunotherapy in Oncology: Advancements and Comparisons Since 2022 Abstract This paper analyzes the recent developments in targeted therapy and immunotherapy for cancer treatment, focusing on advancements made since 2022. It compares these two approaches by examining their mechanisms, effectiveness, and potential applications across

Hidden First Signs of Leukemia That Doctors Often Miss in Primary Care